PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, providing promising enhancements across numerous medical and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, far more reputable alternative for therapeutic use, no